Literature DB >> 31648935

A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor.

Daniel J Bernard1, Courtney L Smith2, Emilie Brûlé3.   

Abstract

Inhibins are gonadal hormones that suppress follicle-stimulating hormone (FSH) synthesis by pituitary gonadotrope cells. The structurally related activins stimulate FSH by signaling through complexes of type I and type II receptors. Two models of inhibin action were proposed in 2000. First, inhibins function as competitive receptor antagonists, binding activin type II receptors with high affinity in the presence of the TGF-β type III coreceptor, betaglycan. Second, immunoglobulin superfamily, member 1 (IGSF1, then called p120) was proposed to mediate inhibin B antagonism of activin signaling via its type I receptor. These ideas have been challenged over the past few years. Rather than playing a role in inhibin action, IGSF1 is involved in the central control of the thyroid gland. Betaglycan binds inhibin A and inhibin B with high affinity, but only functions as an obligate inhibin A coreceptor in murine gonadotropes. There is likely to be a distinct, but currently unidentified coreceptor for inhibin B.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  activin; follicle-stimulating hormone; inhibin; pituitary

Mesh:

Substances:

Year:  2019        PMID: 31648935     DOI: 10.1016/j.tem.2019.08.014

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  6 in total

1.  Low expression of INHB co-receptor TGFBR3 in connection with metastasis and immune infiltration in lung adenocarcinoma.

Authors:  Guoying Zou; Ying Wu; Biqiong Ren; Yuanyuan Wu; Qing Zhu; Junyu He; Zhihong Luo
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Inhibin Inactivation in Female Mice Leads to Elevated FSH Levels, Ovarian Overstimulation, and Pregnancy Loss.

Authors:  Kelly L Walton; Monica P Goney; Zoe Peppas; Jessica M Stringer; Amy Winship; Karla Hutt; Georgia Goodchild; Shreya Maskey; Karen L Chan; Emilie Brûlé; Daniel J Bernard; William A Stocker; Craig A Harrison
Journal:  Endocrinology       Date:  2022-04-01       Impact factor: 5.051

3.  TGFBR3L is an inhibin B co-receptor that regulates female fertility.

Authors:  Emilie Brûlé; Ying Wang; Yining Li; Yeu-Farn Lin; Xiang Zhou; Luisina Ongaro; Carlos A I Alonso; Evan R S Buddle; Alan L Schneyer; Chang-Hyeock Byeon; Cynthia S Hinck; Natalia Mendelev; John P Russell; Mitra Cowan; Ulrich Boehm; Frederique Ruf-Zamojski; Michel Zamojski; Cynthia L Andoniadou; Stuart C Sealfon; Craig A Harrison; Kelly L Walton; Andrew P Hinck; Daniel J Bernard
Journal:  Sci Adv       Date:  2021-12-15       Impact factor: 14.957

4.  Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity.

Authors:  Kentaro Nishi; Wenqiang Fu; Ryoiti Kiyama
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

Review 5.  Hormone supply to the pituitary gland: A comprehensive investigation of female‑related tumors (Review).

Authors:  Wenxiu Tian; Huimin Qi; Zhimei Wang; Sen Qiao; Ping Wang; Junhong Dong; Hongmei Wang
Journal:  Int J Mol Med       Date:  2022-08-10       Impact factor: 5.314

Review 6.  Diagnosis and Management of Central Congenital Hypothyroidism.

Authors:  Peter Lauffer; Nitash Zwaveling-Soonawala; Jolanda C Naafs; Anita Boelen; A S Paul van Trotsenburg
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-09       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.